IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Salix Pharmaceuticals Inc

CUSIP: 79543510 | 4 institutional holders

Quarters

Q3 2014Q2 2014Q1 2014Q4 2013Q3 2013
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2014

Arrowstreet Capital, Limited Partnership12,343
0.0% of portfolio›$1.9K
StyleTurnoverLocationFiled
Arrowstreet Capital, Limited Partnership
12,343$1.9K0.0%GARPHighBoston, MA2014-11-14